酸化保护瘤性RAS免受LZTR1-介导的降解
bioRxiv : the preprint server for biology
|January 16, 2026
概括
研究人员发现了癌细胞控制RAS蛋白稳定性的新方法,发现血液癌症特别容易准这种治疗机制.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 瘤性KRAS和NRAS突变在血液性恶性瘤中普遍存在,但与癌症相比,它们的信号通路仍然不太了解.
- 识别RAS活动的调节者对于发现这些癌症的新生物学和治疗漏洞至关重要.
研究的目的:
- 在多发性骨髓瘤中使用多组体查方法识别RAS活性的新型调节剂.
- 研究控制RAS蛋白稳定性的机制,并探索针对血液癌症中这些途径的潜在治疗策略.
主要方法:
- 在多发性骨髓瘤模型中进行多种OMIC查.
- 对RAS蛋白质脱和降解途径的分析.
- 调查PP1C,LZTR1,PAK1和PAK2在RAS调节中的作用.
- 在血液细胞与癌细胞中RAS蛋白稳定性的比较.
主要成果:
- PP1C在T148处去化RAS,使LZTR1-介导的蛋白质体降解成为可能.
- 在血液癌症中常见的KRAS A146功能获取突变中,LZTR1是无效的.
- 与癌细胞相比,KRAS蛋白在血液细胞中的稳定性是癌细胞的四倍.
- PAK1和PAK2酸化酸T148,保护RAS免受LZTR1降解;向PAK1/2可以增强RAS导向治疗.
结论:
- 已经确定了一种控制RAS稳定的新型调节电路,在血液癌症中具有优先活性.
- 这个电路涉及PP1C,LZTR1,PAK1和PAK2,提供潜在的治疗漏洞.
- 准RAS蛋白稳定机制为血液性恶性瘤提供了一个独特的治疗机会.
相关概念视频
The Ras Gene
7.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.1K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
Protein Kinases and Phosphatases
15.0K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Protein Kinases and Phosphatases
4.4K
4.4K
Phosphorylation
53.6K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.6K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K


